Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →
Tonix Pharmaceuticals Appoints Dr. Seth Lederman As Interim Chief Medical Officer
PUBLIC · TNXPAug 18, 2026•about 7 hours ago
Position
Chief Medical Officer
Company
Tonix Pharmaceuticals Holding Corp
ChathamDescription
On August 18, 2026, Tonix Pharmaceuticals Holding Corp. appointed Dr. Seth Lederman, the Company's President and CEO, as its Interim Chief Medical Officer
Don't miss Tonix Pharmaceuticals Holding Corp's next move
Get an email the moment Tonix Pharmaceuticals Holding Corp changes its leadership, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months